<code id='BCB69FF72B'></code><style id='BCB69FF72B'></style>
    • <acronym id='BCB69FF72B'></acronym>
      <center id='BCB69FF72B'><center id='BCB69FF72B'><tfoot id='BCB69FF72B'></tfoot></center><abbr id='BCB69FF72B'><dir id='BCB69FF72B'><tfoot id='BCB69FF72B'></tfoot><noframes id='BCB69FF72B'>

    • <optgroup id='BCB69FF72B'><strike id='BCB69FF72B'><sup id='BCB69FF72B'></sup></strike><code id='BCB69FF72B'></code></optgroup>
        1. <b id='BCB69FF72B'><label id='BCB69FF72B'><select id='BCB69FF72B'><dt id='BCB69FF72B'><span id='BCB69FF72B'></span></dt></select></label></b><u id='BCB69FF72B'></u>
          <i id='BCB69FF72B'><strike id='BCB69FF72B'><tt id='BCB69FF72B'><pre id='BCB69FF72B'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:98815
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Medicare Advantage beneficiaries sue Humana over algorithm use
          Medicare Advantage beneficiaries sue Humana over algorithm use

          AdobeMedicareAdvantagebeneficiariesonTuesdayfiledaclass-actionlawsuitallegingthatthehealthinsuranceg

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          SEC charges former device maker CEO with $41 million fraud

          From2017to2020,Stimwaveimplantednearly8,000patientswithnervestimulatorscontainingdummypiecesofplasti